ADVERTISEMENT

HER2− Breast Cancer

Videos

Dr Dent Discusses Impact of CVD and HCU in Patients With Breast Cancer

10/21/2021

Susan Dent, MD, discusses the impact of cardiovascular disease (CVD) and health care utilization (HCU) on patients with HR-positive, HER2-negative, advanced breast cancer receiving endocrine therapy.

Susan Dent, MD, discusses the impact of cardiovascular disease (CVD) and health care utilization (HCU) on patients with HR-positive, HER2-negative, advanced breast cancer receiving endocrine therapy.

Susan Dent, MD, discusses the...

10/21/2021

Oncology

Saranya Chumsri, MD

Videos

Dr Chumsri Discusses Real-World Outcomes of ICIs for HR+, HER2- Metastatic Breast Cancer

09/28/2021

Saranya Chumsri, MD, Mayo Clinic, FL, highlights outcomes from a real-world study of ICIs to treat HR+, HER2-, metastatic breast cancer with a high tumor mutational burden.

Saranya Chumsri, MD, Mayo Clinic, FL, highlights outcomes from a real-world study of ICIs to treat HR+, HER2-, metastatic breast cancer with a high tumor mutational burden.

Saranya Chumsri, MD, Mayo...

09/28/2021

Oncology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

September 18 ⁠–⁠ September 20

September 21 ⁠–⁠ September 22

AMP Europe

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

See Full Calendar

Advertisement

Advertisement